CompletedNot Applicable

Effect of Transcutaneous Vagus Nerve Stimulation for Pain Control After Cesarean Delivery

China84 participantsStarted 2025-01-05

Plain-language summary

This study investigates whether non-invasive transcutaneous auricular vagus nerve stimulation can alleviate postoperative pain in patients after cesarean section, and explores its possible mechanisms of action through an exploratory study.

Who can participate

Age range18 Years – 45 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Patients are classified as American Society of Anesthesiologists (ASA) physical status I to III.
✓. Scheduled for elective cesarean delivery under spinal anesthesia.
✓. Patients are aged between 19 to 45 years old.
✓. Patients have provided written informed consent.

Exclusion criteria

✕. Local skin infection occurs in the auricular area during transcutaneous auricular vagus nerve stimulation.
✕. Cases where spinal anesthesia fails and general anesthesia is required.
✕. Patients with conditions such as recurrent alcohol abuse, fever, convulsions, or cardiopulmonary failure.
✕. Patients who have used opioid medications at least 6 months prior to surgery.
✕. Patients who are unable to understand the consent form and study questionnaire, including those with cognitive impairments.
✕. Patients with a history of psychiatric illness.

What they're measuring

Numeric Rating Scale (NRS-11) pain score during movement

Timeframe: 24 hours postoperatively

Trial details

NCT IDNCT06788561

SponsorBeijing Tongren Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-03-15

View on ClinicalTrials.gov More Postoperative Pain, Acute trials